Menaka Sarav, MD
Cards
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileContact Info
Nephrology
330 Cedar Street, Boardman Bldg
New Haven, CT 06510
United States
About
Titles
Assistant Professor of Medicine (Nephrology)
Biography
Dr. Sarav is a nephrologist and clinical informaticist with extensive experience in treating complex renal conditions and a special interest in renal nutrition. She currently serves as an Assistant Professor in the Department of Medicine, Nephrology at Yale University, where she leads multidisciplinary teams to provide advanced medical care for nephrology patients. Dr. Sarav also mentors and teaches residents, fellows, and advanced practice practitioners.
Dr. Sarav completed her nephrology clinical fellowship at the University of Chicago, where she also served as a Post-Doctoral Research Fellow in Dr. Richard J. Quigg’s laboratory, focusing on the mechanisms of proteinuria and immune complex processing in the kidney.
She holds a Master of Management in Clinical Informatics (MMCI) from Duke University School of Medicine, where she undertook extensive coursework in health IT, data science, and healthcare business solutions.
Dr. Sarav’s clinical areas of interests include glomerulonephritis, proteinuric kidney disease, renal nutrition with a focus on slowing down progression of kidney disease. Her research interests include advancing the understanding of renal diseases and improving patient outcomes through clinical trials and informatics tools. She has been the principal investigator for numerous clinical trials, including the NefIgArd study, which evaluates the efficacy and safety of Nefecon in patients with primary IgA nephropathy.
Beyond her clinical and research contributions, Dr. Sarav is an active member of several professional organizations, including the American Society of Nephrology (ASN), the American Society of Parenteral and Enteral Nutrition (ASPEN), and the American Medical Informatics Association (AMIA). She is also committed to mentorship and volunteer efforts through AMIA’s Women in AMIA and HIMSS' Clinician Burnout Committee.
Appointments
Nephrology
Assistant ProfessorPrimary
Other Departments & Organizations
Education & Training
- Non Degree Program
- Duke University School of Medicine, MMCi - Master of Management in Clinical Informatics (2024)
- Clinical Nutrition Fellowship
- Nestlé Nutrition Institute (2018)
- Clinical Fellow
- University of Chicago (2010)
- Research Fellow
- University of Chicago (2008)
- Residency
- St Francis Hospital (2005)
- MD
- Bangalore University (2002)
Research
Research at a Glance
Publications Timeline
Publications
2024
Declining Serum Albumin in the Shadow of Stable Body Mass Index: A Mortality Indicator in Predialysis CKD
Sarav M, Shrestha P, Naseer A, Thomas F, Sumida K, Kalantar-Zadeh K, Kovesdy C. Declining Serum Albumin in the Shadow of Stable Body Mass Index: A Mortality Indicator in Predialysis CKD. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024f9m577ph. DOI: 10.1681/asn.2024f9m577ph.Peer-Reviewed Original ResearchConceptsIMPLEMENTING ADHERENCE TO SGLT2I AND GLP1RA IN PATIENTS WITH CARDIOVASCULAR DISEASE: FINDINGS FROM A PHARMACIST-DRIVEN CARDIODIABETES CLINIC PROGRAM
Lee K, Ikram M, Mishkel G, Ng E, Krupa E, Zahvolskyy L, Davidson D, Gordon R, Billings L, Sarav M, Block R, Erwin J, Qamar A. IMPLEMENTING ADHERENCE TO SGLT2I AND GLP1RA IN PATIENTS WITH CARDIOVASCULAR DISEASE: FINDINGS FROM A PHARMACIST-DRIVEN CARDIODIABETES CLINIC PROGRAM. Journal Of The American College Of Cardiology 2024, 83: 1938. DOI: 10.1016/s0735-1097(24)03928-7.Peer-Reviewed Original Research
2023
Peritoneal Dialysis-Related Peritonitis With Acinetobacter Pittii: A Case Report
Bajaj T, Ismail N, Trivedi A, Sarav M. Peritoneal Dialysis-Related Peritonitis With Acinetobacter Pittii: A Case Report. Journal Of Investigative Medicine High Impact Case Reports 2023, 11: 23247096221148264. PMID: 36624661, PMCID: PMC9834918, DOI: 10.1177/23247096221148264.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPeritoneal dialysis (PD)-related peritonitisPeritoneal dialysis-related peritonitisSensitive to ceftazidimeEnd-stage renal diseaseNidus of infectionIntraperitoneal antibioticsPD catheterWorsening infectionCase reportSevere infectionsRenal diseasePeritonitisInfectionAcinetobacter pittiiSterile techniqueYoung menHand hygieneComplex groupGroup of organismsCeftazidimeComplex group of organismsCatheterPatientsNidusReports
2022
Peritoneal Dialysis Peritonitis With Acinetobacter pittii
Bajaj T, Ismail N, Trivedi A, Sarav M. Peritoneal Dialysis Peritonitis With Acinetobacter pittii. Journal Of The American Society Of Nephrology 2022, 33: 455-455. DOI: 10.1681/asn.20223311s1455c.Peer-Reviewed Original ResearchResults from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
Barratt J, Lafayette R, Kristensen J, Stone A, Cattran D, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Rovin B, Fragale G, Karl A, Losisolo P, Trimarchi H, Hoyos I, Lampo M, Monkowski M, De La Fuente J, Alvarez M, Stoppa D, Chiurchiu C, Novoa P, Orias M, Barron M, Giotto A, Arriola M, Cassini E, Maldonado R, Dionisi M, Ryan J, Toussaint N, Luxton G, Peh C, Levidiotis V, Francis R, Phoon R, Fedosiuk E, Toropilov D, Yakubtsevich R, Mikhailova E, Bovy C, Demoulin N, Hougardy J, Maes B, Speeckaert M, Laurin L, Barbour S, Masse M, Hladunewich M, Reich H, Cournoyer S, Tennankore K, Barbour S, Lv J, Liu Z, Wang C, Li S, Luo Q, Ni Z, Yan T, Fu P, Cheng H, Liu B, Lu W, Wang J, Chen Q, Wang D, Xiong Z, Chen M, Xu Y, Wei J, Pai P, Chen L, Rehorova J, Maixnerova D, Safranek R, Rychlik I, Hruby M, Makela S, Vaaraniemi K, Ortiz F, Alamartine E, Daroux M, Cartery C, Vrtovsnik F, Serre J, Stamellou E, Vielhauer V, Hugo C, Budde K, Otte B, Nitschke M, Ntounousi E, Boletis I, Papagianni A, Goumenos D, Stylianou K, Zermpala S, Esposito C, Cozzolino M, Viganò S, Gesualdo L, Nowicki M, Stompor T, Kurnatowska I, Kim S, Kim Y, Na K, Kim D, Kim S, Porras L, Garcia E, Pamplona I, Segarra A, Goicoechea M, Fellstrom B, Lundberg S, Hemmingsson P, Guron G, Sandell A, Chen C, Tokgoz B, Duman S, Altiparmak M, Ergul M, Maxwell P, Mark P, McCafferty K, Khwaja A, Cheung C, Hall M, Power A, Kanigicherla D, Baker R, Moriarty J, Mohamed A, Aiello J, Canetta P, Ayoub I, Robinson D, Thakar S, Mottl A, Sachmechi I, Fischbach B, Singh H, Mulhern J, Kamal F, Linfert D, Rizk D, Wadhwani S, Sarav M, Campbell K, Coppock G, Luciano R, Sedor J, Avasare R, Lau W. Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy. Kidney International 2022, 103: 391-402. PMID: 36270561, DOI: 10.1016/j.kint.2022.09.017.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsTreatment-emergent adverse eventsSecondary efficacy outcomesTwo-part trialGlomerular filtration rateMonths of treatmentPart AEGFR preservationOral budesonidePrimary IgANEfficacy outcomesNephropathy TrialPrimary endpointAdult patientsAdverse eventsCreatinine ratioIgA nephropathyKidney failureUrine proteinFiltration ratePlaceboTherapeutic potentialPrimary immunoglobulinUPCRMonthsTrials
2020
Trastuzumab-Induced Thrombocytopenia Correlated by Drug-Dependent Platelet Antibodies.
Sullivan K, Kaminer L, Grinblatt D, Campbell N, Nocon C, Harper A, Kang J, Sarav M, Curtis B, Brockstein B. Trastuzumab-Induced Thrombocytopenia Correlated by Drug-Dependent Platelet Antibodies. JCO Oncology Practice 2020, 17: 153-155. PMID: 33270522, DOI: 10.1200/op.20.00734.Peer-Reviewed Original ResearchCitationsAltmetricAcute Kidney Injury Incidence in Hospitalized Patients and Implications for Nutrition Support
Meyer D, Mohan A, Subev E, Sarav M, Sturgill D. Acute Kidney Injury Incidence in Hospitalized Patients and Implications for Nutrition Support. Nutrition In Clinical Practice 2020, 35: 987-1000. PMID: 33140897, DOI: 10.1002/ncp.10595.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAcute kidney injuryAdult patientsRates of acute kidney injuryHospitalized patientsAcute kidney injury incidenceManagement of acute kidney injuryMultiple nutritional problemsAdequate nutritional supportHospitalized adult patientsKidney injuryNutritional supportPatientsNutritional problemsIncidenceInjury incidence
2019
Refeeding Syndrome in the Critically Ill: a Literature Review and Clinician’s Guide
McKnight C, Newberry C, Sarav M, Martindale R, Hurt R, Daley B. Refeeding Syndrome in the Critically Ill: a Literature Review and Clinician’s Guide. Current Gastroenterology Reports 2019, 21: 58. PMID: 31758276, DOI: 10.1007/s11894-019-0724-3.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsRefeeding syndromeCritically ill patientsNational Institute for Health and Clinical Excellence criteriaAssessment toolDefinition of RFSNutrition care planModerate to severe malnutritionClinical assessment toolIll patientsCritically ill patient populationNutritional assessment toolManagement of refeeding syndromeDecrease complication ratesCare planningIll patient populationLife-threatening conditionMethods of diagnosisMetabolic teamComplication rateGastrointestinal complicationsClinician's GuideDecrease morbiditySevere malnutritionNutritional supportElectrolyte imbalanceKetogenic Diet: from the Historical Records to Use in Elite Athletes
Kaspar M, Austin K, Huecker M, Sarav M. Ketogenic Diet: from the Historical Records to Use in Elite Athletes. Current Nutrition Reports 2019, 8: 340-346. PMID: 31713719, DOI: 10.1007/s13668-019-00294-0.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsImprove body compositionHuman athletic performanceLow-carbohydrate/high-fatElite athletesStrength activitiesAthletic performanceOutcome measuresBody compositionFindingsMultiple studiesAthletesReview studiesSystem of exercisesLow-carbohydrateMultiple studiesLiterature/evidenceOutcomesExerciseEnduranceInterventionSportsAvailable dataLCKDImpaired performanceProtein Supplementation in Sport: Source, Timing, and Intended Benefits
Huecker M, Sarav M, Pearlman M, Laster J. Protein Supplementation in Sport: Source, Timing, and Intended Benefits. Current Nutrition Reports 2019, 8: 382-396. PMID: 31713177, DOI: 10.1007/s13668-019-00293-1.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsBenefit purposesSportsMulti-billion-dollar marketClinically relevant outcomesDietary protein consumptionAthletesHealthy subjectsReviewThe purposeHigh-protein dietMarketEffects of protein supplementationLong-term implicationsShort-termExercise activitiesRelevant outcomesNutrient timingOptimal dietary proteinProtein consumptionSupplement formImplicationsProtein supplementationSupplementationOutcomesPurposesDietary protein
Clinical Care
Overview
Clinical Specialties
Board Certifications
Nephrology
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2020
- Original Certification Date
- 2010
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews
Get In Touch
Contacts
Nephrology
330 Cedar Street, Boardman Bldg
New Haven, CT 06510
United States
Administrative Support
Locations
Boardman Building
Academic Office
330 Cedar Street
New Haven, CT 06510
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.